Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review

Victoria Hall, Reimar W Thomsen, Ole Henriksen, Nicolai Lohse, Victoria Hall, Reimar W Thomsen, Ole Henriksen, Nicolai Lohse

Abstract

Background: Diabetes prevalence is increasing globally, and Sub-Saharan Africa is no exception. With diverse health challenges, health authorities in Sub-Saharan Africa and international donors need robust data on the epidemiology and impact of diabetes in order to plan and prioritise their health programmes. This paper aims to provide a comprehensive and up-to-date review of the epidemiological trends and public health implications of diabetes in Sub-Saharan Africa.

Methods: We conducted a systematic literature review of papers published on diabetes in Sub-Saharan Africa 1999-March 2011, providing data on diabetes prevalence, outcomes (chronic complications, infections, and mortality), access to diagnosis and care and economic impact.

Results: Type 2 diabetes accounts for well over 90% of diabetes in Sub-Saharan Africa, and population prevalence proportions ranged from 1% in rural Uganda to 12% in urban Kenya. Reported type 1 diabetes prevalence was low and ranged from 4 per 100,000 in Mozambique to 12 per 100,000 in Zambia. Gestational diabetes prevalence varied from 0% in Tanzania to 9% in Ethiopia. Proportions of patients with diabetic complications ranged from 7-63% for retinopathy, 27-66% for neuropathy, and 10-83% for microalbuminuria. Diabetes is likely to increase the risk of several important infections in the region, including tuberculosis, pneumonia and sepsis. Meanwhile, antiviral treatment for HIV increases the risk of obesity and insulin resistance. Five-year mortality proportions of patients with diabetes varied from 4-57%. Screening studies identified high proportions (> 40%) with previously undiagnosed diabetes, and low levels of adequate glucose control among previously diagnosed diabetics. Barriers to accessing diagnosis and treatment included a lack of diagnostic tools and glucose monitoring equipment and high cost of diabetes treatment. The total annual cost of diabetes in the region was estimated at US$67.03 billion, or US$8836 per diabetic patient.

Conclusion: Diabetes exerts a significant burden in the region, and this is expected to increase. Many diabetic patients face significant challenges accessing diagnosis and treatment, which contributes to the high mortality and prevalence of complications observed. The significant interactions between diabetes and important infectious diseases highlight the need and opportunity for health planners to develop integrated responses to communicable and non-communicable diseases.

References

    1. WHO. The Global Burden of Disease: 2004 Update. World Health Organisation: Geneva; 2004.
    1. Sicree R, Shaw J, Zimmet. Diabetes Atlas, IDF. 4. International Diabetes Federation: Brussels; 2009. The Global Burden: Diabetes and Impaired Glucose Tolerance.
    1. UNAIDS. 2010 Report on the global AIDS epidemic. Geneva: UNAIDS; 2010.
    1. World Health Organisation. WHO Global Tuberculosis Control Report 2010. WHO: Geneva; 2010.
    1. World Health Organisation. World Malaria Report 2010. WHO: Geneva; 2010.
    1. Saydah SH. et al.Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156(8):714–9. doi: 10.1093/aje/kwf111.
    1. Brown WV. Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection. Am J Cardiol. 2008;102(12A):10L–13L.
    1. Kornum JB, T R, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care. 2008;31(8):1541–5. doi: 10.2337/dc08-0138.
    1. Thomsen RW, H H, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care. 2004;27(4):1143–7.
    1. Thomsen RW, H H, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis. 2005;40(4):628–31. doi: 10.1086/427699.
    1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. doi: 10.1371/journal.pmed.0050152.
    1. Rudan I. et al.Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86(5):408–16. doi: 10.2471/BLT.07.048769.
    1. Seale AC. et al.Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa. Lancet Infect Dis. 2009;9(7):428–38. doi: 10.1016/S1473-3099(09)70172-0.
    1. Mayanja BN, Septicaemia in a population-based HIV clinical cohort in rural Uganda, 1996-2007: incidence, aetiology, antimicrobial drug resistance and impact of antiretroviral therapy. Trop Med Int Health. pp. 697–705.
    1. Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. pp. 417–32.
    1. Steen TW, Aruwa JE, Hone NM. The epidemiology of adult lung disease in Botswana. Int J Tuberc Lung Dis. 2001;5(8):775–82.
    1. Lonnroth K, Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet. pp. 1814–29.
    1. World Health Organisation. 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. WHO, Geneva; 2008.
    1. Levitt NS. Diabetes in Africa: epidemiology, management and healthcare challenges. Heart. 2008;94(11):1376–82. doi: 10.1136/hrt.2008.147306.
    1. Gill GV. et al.A sub-Saharan African perspective of diabetes. Diabetologia. 2009;52(1):8–16. doi: 10.1007/s00125-008-1167-9.
    1. Mbanya JC. et al.Diabetes in sub-Saharan Africa. Lancet. 2010;375(9733):2254–66. doi: 10.1016/S0140-6736(10)60550-8.
    1. Mbanya JC. et al.Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care. 1999;22(3):434–40. doi: 10.2337/diacare.22.3.434.
    1. Sobngwi E. et al.Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord. 2002;26(7):1009–16.
    1. MOH. Cameroon Burden of Diabetes Project (Cambod): Baseline Survey Report. Ministry of Health, Cameroon; 2004.
    1. Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract. 2002;56(3):197–205. doi: 10.1016/S0168-8227(01)00374-6.
    1. Balde NM. et al.Diabetes and impaired fasting glucose in rural and urban populations in Futa Jallon (Guinea): prevalence and associated risk factors. Diabetes Metab. 2007;33(2):114–20. doi: 10.1016/j.diabet.2006.10.001.
    1. Christensen DL. et al.Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract. 2009;84(3):303–10. doi: 10.1016/j.diabres.2009.03.007.
    1. Mathenge W, Foster A, Kuper H. Urbanization, ethnicity and cardiovascular risk in a population in transition in Nakuru, Kenya: a population-based survey. BMC Public Health. p. 569.
    1. Nyenwe EA. et al.Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Res Clin Pract. 2003;62(3):177–85. doi: 10.1016/j.diabres.2003.07.002.
    1. Oladapo OO, A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr. pp. 26–31.
    1. Erasmus RT. et al.Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Transkei, South Africa. S Afr Med J. 2001;91(2):157–60.
    1. Alberts M. et al.Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prev Rehabil. 2005;12(4):347–54. doi: 10.1097/01.hjr.0000174792.24188.8e.
    1. Motala AA. et al.Diabetes and other disorders of glycemia in a rural South African community: prevalence and associated risk factors. Diabetes Care. 2008;31(9):1783–8. doi: 10.2337/dc08-0212.
    1. Aspray TJ. et al.Rural and urban differences in diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg. 2000;94(6):637–44. doi: 10.1016/S0035-9203(00)90216-5.
    1. Maher D, Distribution of hyperglycaemia and related cardiovascular disease risk factors in low-income countries: a cross-sectional population-based survey in rural Uganda. Int J Epidemiol. pp. 160–71.
    1. MOH. National Survey: Zimbabwe Non-Communicable Disease Risk Factors (ZiNCoDs). Preliminary Report. Ministry of Health and Child Welfare, Zimbabwe; 2005.
    1. Longo-Mbenza B, Metabolic syndrome, aging, physical inactivity, and incidence of type 2 diabetes in general African population. Diab Vasc Dis Res. pp. 28–39.
    1. Elamin A, Eltayeb B, Tuvemo T. High Incidence of Type I Diabetes Mellitus in Sudanese children. Ann Saudi Med. 1997;17(4):478–480.
    1. Alemu S. et al.Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutrition-related diabetes? Diabetologia. 2009;52(9):1842–5. doi: 10.1007/s00125-009-1433-5.
    1. Beran D, Yudkin JS, de Courten M. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care. 2005;28(9):2136–40. doi: 10.2337/diacare.28.9.2136.
    1. Swai AB, Lutale JL, McLarty DG. Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania. BMJ. 1993;306(6892):1570–2. doi: 10.1136/bmj.306.6892.1570.
    1. Seyoum B. et al.Prevalence of gestational diabetes mellitus in rural pregnant mothers in northern Ethiopia. Diabetes Res Clin Pract. 1999;46(3):247–51. doi: 10.1016/S0168-8227(99)00101-1.
    1. Mamabolo RL. et al.Prevalence of gestational diabetes mellitus and the effect of weight on measures of insulin secretion and insulin resistance in third-trimester pregnant rural women residing in the Central Region of Limpopo Province, South Africa. Diabet Med. 2007;24(3):233–9. doi: 10.1111/j.1464-5491.2006.02073.x.
    1. Hailu A, Kebede D. High-risk pregnancies in urban and rural communities in central part of Ethiopia. East Afr Med J. 1994;71(10):661–6.
    1. Swai AB. et deterioration of oral glucose tolerance during pregnancy in rural Tanzania. Diabet Med. 1991;8(3):254–7. doi: 10.1111/j.1464-5491.1991.tb01581.x.
    1. Ranchod HA, Vaughan JE, Jarvis P. Incidence of gestational diabetes at Northdale Hospital, Pietermaritzburg. S Afr Med J. 1991;80(1):14–6.
    1. Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: Epidemiology and clinical specificities. Diabetes and Metabolism. 2001. pp. 628–634.
    1. Gill GV, Huddle KR, Monkoe G. Long-term (20 years) outcome and mortality of Type 1 diabetic patients in Soweto, South Africa. Diabet Med. 2005;22(12):1642–6. doi: 10.1111/j.1464-5491.2005.01712.x.
    1. Lester FT. Clinical features, complications and mortality in type 1 (insulin-dependent) diabetic patients in Addis Ababa, Ethiopia, 1976-1990. Q J Med. 1992;83(301):389–99.
    1. McLarty DG, Kinabo L, Swai AB. Diabetes in tropical Africa: a prospective study, 1981-7. II. Course and prognosis. BMJ. 1990;300(6732):1107–10. doi: 10.1136/bmj.300.6732.1107.
    1. Wanjohi FW. et al.Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in black Africans. East Afr Med J. 2002;79(8):399–404.
    1. Ndip EA, Tchakonte B, Mbanya JC. A study of the prevalence and risk factors of foot problems in a population of diabetic patients in cameroon. Int J Low Extrem Wounds. 2006;5(2):83–8. doi: 10.1177/1534734606288413.
    1. Odusan O, Familoni OB, Raimi TH. Correlates of cardiac autonomic neuropathy in Nigerian patients with type 2 diabetes mellitus. Afr J Med Med Sci. 2008;37(4):315–20.
    1. Ahmed AM, Hussein A, Ahmed NH. Diabetic autonomic neuropathy. Saudi Med J. 2000;21(11):1034–7.
    1. Kengne AP. et al.Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in cameroon. Int J Low Extrem Wounds. 2009;8(4):180–6. doi: 10.1177/1534734609349704.
    1. Ogbera AO. et assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006;5(4):244–9. doi: 10.1177/1534734606294538.
    1. Gulam-Abbas Z. et al.Clinical outcome of diabetes patients hospitalized with foot ulcers, Dar es Salaam, Tanzania. Diabet Med. 2002;19(7):575–9. doi: 10.1046/j.1464-5491.2002.00740.x.
    1. Mengesha AY. Spectrum of eye disorders among diabetes mellitus patients in Gaborone, Botswana. Trop Doct. 2006;36(2):109–11. doi: 10.1258/004947506776593576.
    1. Sobngwi E. et al.Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999;44(3):191–6. doi: 10.1016/S0168-8227(99)00052-2.
    1. Seyoum B. et al.Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J. 2001;39(2):123–31.
    1. Rotimi C. et al.Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients. Ethn Dis. 2003;13(2 Suppl 2):S110–7.
    1. Omolase CO, Diabetic retinopathy in a Nigerian community. Singapore Med J. pp. 56–9.
    1. Mwendwa FM. et al.Risk factor profile and the occurrence of microvascular complications in short-term type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi. East Afr Med J. 2005;82(12 Suppl):S163–72.
    1. Mwale C, Karimurio J, Njuguna M. Refractive errors in type 2 diabetic patients. East Afr Med J. 2007;84(6):259–63.
    1. Motala AA. et al.Microvascular complications in South African patients with long-duration diabetes mellitus. S Afr Med J. 2001;91(11):987–92.
    1. Read O, Cook C. Retinopathy in diabetic patients evaluated at a primary care clinic in Cape Town. S Afr Med J. 2007;97(10):941–2. 944.
    1. Mash B. et al.Screening for diabetic retinopathy in primary care with a mobile fundal camera--evaluation of a South African pilot project. S Afr Med J. 2007;97(12):1284–8.
    1. Majaliwa ES. et al.Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania. Diabetes Care. 2007;30(9):2187–92. doi: 10.2337/dc07-0594.
    1. Unuigbe EI. et al.Microalbuminuria and associated factors in newly diagnosed diabetics. Niger Postgrad Med J. 2001;8(4):187–92.
    1. Kalk WJ, Joffe BI. Differences in coronary heart disease prevalence and risk factors in African and White patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;77(1):107–12. doi: 10.1016/j.diabres.2006.10.014.
    1. Eghan BA Jr, Frempong MT, Adjei-Poku M. Prevalence and predictors of microalbuminuria in patients with diabetes mellitus: a cross-sectional observational study in Kumasi, Ghana. Ethn Dis. 2007;17(4):726–30.
    1. Agaba EI, Agaba PA, Puepet FH. Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria. Afr J Med Med Sci. 2004;33(1):19–22.
    1. Adetunji OR. et al.Microalbuminuria and clinical correlates in black African patients with type 2 diabetes. West Afr J Med. 2006;25(4):279–83.
    1. Lutale JJ. et al.Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania. BMC Nephrol. 2007;8:2. doi: 10.1186/1471-2369-8-2.
    1. Makuyana D. et al.Asymptomatic bacteriuria among outpatients with diabetes mellitus in an urban black population. Cent Afr J Med. 2002;48(7-8):78–82.
    1. Abbas ZG, Archibald LK. Challenges for management of the diabetic foot in Africa: doing more with less. Int Wound J. 2007;4(4):305–13.
    1. Abbas ZG, Gill GV, Archibald LK. The epidemiology of diabetic limb sepsis: an African perspective. Diabet Med. 2002;19(11):895–9. doi: 10.1046/j.1464-5491.2002.00825.x.
    1. Beran D, Yudkin JS. Diabetes Atlas, IDF. 4. International Diabetes Federation: Brussels; 2009. Looking beyond the issue of access to insulin: What is needed for propoer Diabetes care in resource-poor settings.
    1. Mendis S. et al.The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007;85(4):279–88. doi: 10.2471/BLT.06.033647.
    1. Neuhann HF. et al.Diabetes care in Kilimanjaro region: clinical presentation and problems of patients of the diabetes clinic at the regional referral hospital-an inventory before structured intervention. Diabet Med. 2002;19(6):509–13. doi: 10.1046/j.1464-5491.2002.00673.x.
    1. Elrayah H. et al.Economic burden on families of childhood type 1 diabetes in urban Sudan. Diabetes Res Clin Pract. 2005;70(2):159–65. doi: 10.1016/j.diabres.2005.03.034.
    1. Kirigia JM. et al.Economic burden of diabetes mellitus in the WHO African region. BMC Int Health Hum Rights. 2009;9:6. doi: 10.1186/1472-698X-9-6.
    1. International Monetary Fund. World Economic Outlook Database, April. 2009. [cited 2011 06/04/2011]
    1. Chale SS, S A, Mujinja PGM, McLarty DG. Must diabetes be a fatal disease in Africa? Study of costs of treatment. BMJ. 1992. pp. 1215–18.
    1. Pepper DJ. et al.Hyperglycaemic emergency admissions to a secondary-level hospital - an unnecessary financial burden. S Afr Med J. 2007;97(10):963–7.
    1. Marine N. et al.Diabetes, hyperglycemia and glycosuria among Indians, Malays and Africans (Bantu) in Cape Town, South Africa. Diabetes. 1969;18(12):840–57.
    1. Motala AA, Omar MA, Pirie FJ. Diabetes in Africa. Epidemiology of type 1 and type 2 diabetes in Africa. J Cardiovasc Risk. 2003;10(2):77–83. doi: 10.1097/00043798-200304000-00002.
    1. McLarty DG, Pollitt C, Swai AB. Diabetes in Africa. Diabet Med. 1990;7(8):670–84. doi: 10.1111/j.1464-5491.1990.tb01470.x.
    1. Faeh D. et al.Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight. BMC Public Health. 2007;7:163. doi: 10.1186/1471-2458-7-163.
    1. Levitt NS. et al.Application of the new ADA criteria for the diagnosis of diabetes to population studies in sub-Saharan Africa. American diabetes association. Diabet Med. 2000;17(5):381–5. doi: 10.1046/j.1464-5491.2000.00264.x.
    1. Shaw JE. et al.Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care. 1999;22(3):399–402. doi: 10.2337/diacare.22.3.399.
    1. Motala AA. Diabetes trends in Africa. Diabetes Metab Res Rev. 2002;18(Suppl 3):S14–20.
    1. UN-HABITAT. State of the World's Cities: Trends in Sub-Saharan Africa. UN-HABITAT: Nairobi; 2004.
    1. Holman RR. et al.10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008;359(15):1577–1589. doi: 10.1056/NEJMoa0806470.
    1. Stevenson CR. et al.Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn. 2007;3(3):228–45. doi: 10.1177/1742395307081502.
    1. Stevenson CR. et al.Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007;7:234. doi: 10.1186/1471-2458-7-234.
    1. Ponce-De-Leon A. et al.Tuberculosis and diabetes in southern Mexico. Diabetes Care. 2004;27(7):1584–90. doi: 10.2337/diacare.27.7.1584.
    1. Leung CC. et al.Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol. 2008;167(12):1486–94. doi: 10.1093/aje/kwn075.
    1. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997;87(4):574–9. doi: 10.2105/AJPH.87.4.574.
    1. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–46. doi: 10.1016/S1473-3099(09)70282-8.
    1. Young FCJ, Johnstone LK, Unwin NC. A review of co-morbifity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome. Globalization and Health. 2009;5(9)
    1. Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med. 2005;118(Suppl 2):23S–28S.
    1. Mallon PW, Cooper DA, Carr A. HIV-associated lipodystrophy. HIV Med. 2001;2(3):166–73. doi: 10.1046/j.1468-1293.2001.00071.x.
    1. Lichtenstein KA. et al.Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS. 2001;15(11):1389–98. doi: 10.1097/00002030-200107270-00008.
    1. Jevtovic DJ. et al.The metabolic syndrome, an epidemic among HIV-infected patients on HAART. Biomed Pharmacother. 2009;63(5):337–42. doi: 10.1016/j.biopha.2008.09.011.
    1. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549–54. doi: 10.1007/s00125-006-0570-3.
    1. Muller LM. et al.Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281–8. doi: 10.1086/431587.
    1. Kornum JB. et al.Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care. 2008;31(8):1541–5. doi: 10.2337/dc08-0138.
    1. Jackson ML. et al.The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642–50. doi: 10.1086/425615.
    1. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26(2):510–3. doi: 10.2337/diacare.26.2.510.
    1. O'Meara ES. et al.Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc. 2005;53(7):1108–16. doi: 10.1111/j.1532-5415.2005.53352.x.
    1. Thomsen RW. et al.Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care. 2004;27(5):1143–7. doi: 10.2337/diacare.27.5.1143.
    1. Thomsen RW. et al.Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis. 2005;40(4):628–31. doi: 10.1086/427699.
    1. Adeleke SI. et al.Childhood diabetes mellitus in Kano, North West, Nigeria. Niger J Med. 2010;19(2):145–7.
    1. Factor SH. et al.Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 2003;9(8):970–7.
    1. Jackson LA. et al.Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123(6):415–20.
    1. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis. 2008;198(3):336–43. doi: 10.1086/589717.
    1. Maher D, Smeeth L, Sekajugo J. Health transition in Africa: practical policy proposals for primary care. Bull World Health Organ. pp. 943–8.
    1. Zhang PZX, Brown JB, Vistisen D, Sicree RA, Shaw J, Nichols GA. Diabetes Atlas, IDF. 4. International Diabetes Federation: Brussels; 2009. Economic Impact of Diabetes.
    1. Bradshaw D. et al.Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J. 2007;97(8 Pt 2):700–6.
    1. Okesina AB. et al.Prevalence of some risk factors of coronary heart disease in a rural Nigerian population. East Afr Med J. 1999;76(4):212–6.
    1. Erasmus RT. et al.Assessment of glycaemic control in stable type 2 black South African diabetics attending a peri-urban clinic. Postgrad Med J. 1999;75(888):603–6.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa